康艾注射液联合抗生素治疗老年慢性阻塞性肺疾病急性加重期的疗效观察  

Clinical observation on Kang-ai-zhu-she-ye combined with antibiotics in the treatment of acute exacerbations of chronic obstructive pulmonary disease in elderly patients

作　　者：李衡[1] 曾礼华[1] 谭晚晴[1] 

机构地区：[1]湘潭市第一人民医院呼吸内科,411101

出　　处：《国际呼吸杂志》2012年第5期344-346,共3页International Journal of Respiration

摘　　要：目的观察康艾注射液联合抗生素治疗老年慢性阻塞性肺疾病急性加重期的疗效。方法将72例老年慢性阻塞性肺疾病患者随机分为36例治疗组和36例对照组。两组患者均给予抗生素抗感染，治疗组同时加用康艾注射液，其余治疗均相同。对两组患者治疗前后的APACHEⅡ评分、呼吸困难评分及临床疗效进行评估。结果两组患者相较于本组治疗前，APACHEⅡ评分、呼吸困难评分差异均有统计学意义（P〈0．05）。在APACHEⅡ评分、呼吸困难评分及临床疗效上，治疗组相对对照组治疗后比较差异有统计学意义（P〈0．05）。结论康艾注射液联合抗生素是治疗老年慢性阻塞性肺疾病急性加重期的有效疗法。Objective To observe the clinical effect of Kang-ai-zhu-she-ye combined with antibiotics in the treatment of chronic obstructive pulmonary disease in acute exacerbation stage in elderly patients. Methods 76 cases of chronic obstructive pulmonary disease were randomly divided into two groups. Both of the two groups were given biotics, patients in the treatment group were treated by the combination of Kang-ai-zhu-she-ye and antibiotics. The APACHE II scores, the dyspnea scores and clinical efficacy before and after treatment was compared in two groups. Results The APACHE II scores, the dyspnea score,after treatment was impmved in comparison with those before treatment in two groups （ P 0.05）. There were significant difference between two groups in The APACHE II scores,the dyspnea score and clinical efficacy, which the treatment group were better than the control group （P 〈 0.05 ）. Conclusions Kang-ai-zhu-she-ye combined with antibiotics in the treatment of chronic obstructive pulmonary disease in acute exacerbation stage is effective.

关 键 词：康艾注射液 抗生素 慢性阻塞性肺疾病急性加重期 老年 

分 类 号：R563.9[医药卫生—呼吸系统]